Literature DB >> 17564818

Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression.

Georgia Agiostratidou1, James Hulit, Greg R Phillips, Rachel B Hazan.   

Abstract

The cadherin family of adhesion molecules regulates cell-cell interactions during development and in tissues. The prototypical cadherin, E-cadherin, is responsible for maintaining interactions of epithelial cells and is frequently downregulated during tumor progression. N-cadherin, normally found in fibroblasts and neural cells, can be upregulated during tumor progression and can increase the invasiveness of tumor cells. The proinvasive effects of N-cadherin expression in tumor cells result from two possible mechanisms: promotion of tumor cell interactions with the N-cadherin-expressing microenvironment, or enhancement of signaling via the fibroblast growth factor receptor. The downregulation of E-cadherin and the upregulation of N-cadherin in tumors may be a result of an epithelial to mesenchymal transformation (EMT) of tumor cells, which is notoriously difficult to detect in vivo. Double labeling of individual tumors with specific E- and N-cadherin antibodies suggests that EMT can occur heterogeneously and/or transiently within an invasive tumor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17564818     DOI: 10.1007/s10911-007-9044-6

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  57 in total

1.  A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor.

Authors:  Kimita Suyama; Irina Shapiro; Mitchell Guttman; Rachel B Hazan
Journal:  Cancer Cell       Date:  2002-10       Impact factor: 31.743

2.  Identification of a cadherin cell adhesion recognition sequence.

Authors:  O W Blaschuk; R Sullivan; S David; Y Pouliot
Journal:  Dev Biol       Date:  1990-05       Impact factor: 3.582

Review 3.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

4.  N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.

Authors:  James Hulit; Kimita Suyama; Su Chung; Rinat Keren; Georgia Agiostratidou; Weisong Shan; Xinyuan Dong; Terence M Williams; Michael P Lisanti; Karen Knudsen; Rachel B Hazan
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

5.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

6.  Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors.

Authors:  Weigang Wang; Sumanta Goswami; Kyle Lapidus; Amber L Wells; Jeffrey B Wyckoff; Erik Sahai; Robert H Singer; Jeffrey E Segall; John S Condeelis
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

Review 7.  Presenilin diversifies its portfolio.

Authors:  Annette L Parks; Daniel Curtis
Journal:  Trends Genet       Date:  2007-02-05       Impact factor: 11.639

8.  Assembly of the cadherin-catenin complex in vitro with recombinant proteins.

Authors:  H Aberle; S Butz; J Stappert; H Weissig; R Kemler; H Hoschuetzky
Journal:  J Cell Sci       Date:  1994-12       Impact factor: 5.285

9.  N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility.

Authors:  J B Kim; S Islam; Y J Kim; R S Prudoff; K M Sass; M J Wheelock; K R Johnson
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

10.  Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.

Authors:  A Lochter; S Galosy; J Muschler; N Freedman; Z Werb; M J Bissell
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

View more
  44 in total

1.  Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma.

Authors:  Shyamal Dilhan Weeraratne; Vladimir Amani; Natalia Teider; Jessica Pierre-Francois; Dominic Winter; Min Jeong Kye; Soma Sengupta; Tenley Archer; Marc Remke; Alfa H C Bai; Peter Warren; Stefan M Pfister; Judith A J Steen; Scott L Pomeroy; Yoon-Jae Cho
Journal:  Acta Neuropathol       Date:  2012-03-10       Impact factor: 17.088

Review 2.  Noncanonical TGF-β signaling during mammary tumorigenesis.

Authors:  Jenny G Parvani; Molly A Taylor; William P Schiemann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-31       Impact factor: 2.673

3.  Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.

Authors:  Chandra M V Goparaju; Harvey I Pass; Justin D Blasberg; Nathalie Hirsch; Jessica S Donington
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

Review 4.  MiRNAs-mediated cisplatin resistance in breast cancer.

Authors:  Xiu Chen; Peng Lu; Ying Wu; Dan-Dan Wang; Siying Zhou; Su-Jin Yang; Hong-Yu Shen; Xiao-Hui Zhang; Jian-Hua Zhao; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-07-22

5.  Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate.

Authors:  Renaud Warin; William H Chambers; Douglas M Potter; Shivendra V Singh
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

6.  FRK inhibits migration and invasion of human glioma cells by promoting N-cadherin/β-catenin complex formation.

Authors:  Qiong Shi; Xu Song; Jun Wang; Jia Gu; Weijian Zhang; Jinxia Hu; Xiuping Zhou; Rutong Yu
Journal:  J Mol Neurosci       Date:  2014-06-27       Impact factor: 3.444

7.  Loss of retinal cadherin facilitates mammary tumor progression and metastasis.

Authors:  Georgia Agiostratidou; Maomi Li; Kimita Suyama; Ines Badano; Rinat Keren; Su Chung; Amy Anzovino; James Hulit; Binzhi Qian; Boumediene Bouzahzah; Eliseo Eugenin; Olivier Loudig; Greg R Phillips; Joseph Locker; Rachel B Hazan
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

Review 8.  The relevance of the TGF-β Paradox to EMT-MET programs.

Authors:  Chevaun D Morrison; Jenny G Parvani; William P Schiemann
Journal:  Cancer Lett       Date:  2013-03-05       Impact factor: 8.679

9.  BRCA1 and p53 regulate critical prostate cancer pathways.

Authors:  P De Luca; C P Moiola; F Zalazar; K Gardner; E S Vazquez; A De Siervi
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-05-14       Impact factor: 5.554

10.  Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.

Authors:  Chandra P Prasad; Gayatri Rath; Sandeep Mathur; Dinesh Bhatnagar; Rajinder Parshad; Ranju Ralhan
Journal:  BMC Cancer       Date:  2009-09-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.